HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Andrew Koustenis Selected Research

Ototoxicity

6/2013Pemetrexed in head and neck cancer: a systematic review.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Andrew Koustenis Research Topics

Disease

4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2022 - 10/2013
3Neoplasms (Cancer)
01/2016 - 08/2012
3Head and Neck Neoplasms (Head and Neck Cancer)
06/2013 - 08/2012
1Adenocarcinoma of Lung
05/2022
1Breast Neoplasms (Breast Cancer)
09/2017
1Disease Progression
09/2017
1Retinal Diseases
01/2017
1Sarcoma (Soft Tissue Sarcoma)
01/2016
1Ototoxicity
06/2013
1Oropharyngeal Neoplasms
10/2012

Drug/Important Bio-Agent (IBA)

5Pemetrexed (MTA)FDA Link
03/2016 - 08/2012
5Cisplatin (Platino)FDA LinkGeneric
03/2016 - 08/2012
2abemaciclibIBA
09/2017 - 01/2016
2PlatinumIBA
03/2016 - 01/2016
1Immune Checkpoint InhibitorsIBA
05/2022
1Codon (Codons)IBA
05/2022
1defactinibIBA
05/2022
1Hormones (Hormone)IBA
09/2017
1Retinaldehyde (Retinal)IBA
01/2017
1Etoposide (VP 16)FDA LinkGeneric
03/2016
1Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2016
1Carboplatin (JM8)FDA LinkGeneric
10/2013

Therapy/Procedure

4Drug Therapy (Chemotherapy)
05/2022 - 10/2013
3Therapeutics
03/2016 - 08/2012
3Radiotherapy
03/2016 - 06/2013
1Consolidation Chemotherapy
03/2016
1Chemoradiotherapy
03/2016